October 30, 2024
Agilera Pharma, a Norwegian CDMO focused on radiopharmaceuticals, explores ownership options advised by ABG Sundal Collier, according to multiple sources (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights